Parallel Evolution of Linezolid Resistant Staphylococcus aureus in Patients with Cystic Fibrosis

Mostrar otras versiones (1)

BACKGROUND: Linezolid is an antibiotic used to treat serious Staphylococcus aureus infections. Resistance to linezolid is considered rare but could emerge with repeated dosing. We recently reported widespread prescription of linezolid for a cohort of patients with cystic fibrosis (CF). OBJECTIVES: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitcher, Nicholas J., Feder, Andries, Bolden, Nicholas, Zirbes, Christian F., Pamatmat, Anthony J., Boyken, Linda, Hill, Jared J., Thurman, Andrew L., Reeb, Valérie C., Porterfield, Harry S., Moustafa, Ahmed M., Planet, Paul J., Fischer, Anthony J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187253/
https://www.ncbi.nlm.nih.gov/pubmed/37205485
http://dx.doi.org/10.1101/2023.05.02.539145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187253/
https://www.ncbi.nlm.nih.gov/pubmed/37205485
http://dx.doi.org/10.1101/2023.05.02.539145

Ejemplares similares